The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

London marked the slowest first half-year for IPO volume since 1997, a grim milestone punctuated by a report that AstraZeneca ...

In turn, while the overall impact from them is still yet to be seen, Mr Bailey says tightening rates further could be more ...

AstraZeneca’s chief executive has discussed quitting Britain in a move that would deal a significant blow to the City of ...

Suggestions that AstraZeneca might cross the Atlantic should act as a huge wake-up call.

The boss of Britain’s most valuable company, Astrazeneca, has reportedly voiced his preference to move the firm’s stock ...

It was already a bad enough week for the Prime Minister Sir Keir Starmer and the Chancellor Rachel Reeves, what with the ...

AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the ...

The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.

Sky's James Sillars writes that a government, struggling for authority and prioritising economic growth, can not afford to ...

Pressure is piling on London's stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet another blow this week. Stream Connecticut News ...